Numerous studies have shown that down-regulation of GRN expression is associated with inflammation in multiple neurodegenerative diseases such as amyotrophic lateral sclerosis, frontotemporal dementia, Alzheimer's disease and Parkinson's disease (26). Here, GRN is linked to Alzheimer disease.